DarioHealth Reports 32.9% Revenue Growth to $27M for 2024

DarioHealth Corp. reported a strong financial performance for 2024, with total revenue increasing by 32.9% to $27 million, driven by the acquisition of Twill and growth in its B2B2C channels. The company achieved a significant 398% increase in recurring revenues, reflecting a strategic focus on expanding its digital health solutions for chronic condition management. Despite a net loss of $42.7 million, this was an improvement from the previous year's loss of $59.4 million, indicating progress in operational efficiency. DarioHealth's gross profit margin rose to 49.1%, up from 29.4% the year before, as the company integrates AI-driven solutions into its offerings. Looking ahead, DarioHealth aims to achieve operational cash flow breakeven by the end of 2025 while expanding its client base and enhancing product offerings. The acquisition of Twill is expected to bolster its market position, although the company acknowledges potential integration challenges.